- Home
- COLL vs HUYA Comparison
COLL vs HUYA Comparison
Compare COLL & HUYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- HUYA
- Stock Information
- Founded
- COLL 2002
- HUYA 2014
- Country
- COLL United States
- HUYA China
- Employees
- COLL N/A
- HUYA N/A
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- HUYA Computer Software: Programming Data Processing
- Sector
- COLL Health Care
- HUYA Technology
- Exchange
- COLL Nasdaq
- HUYA Nasdaq
- Market Cap
- COLL 958.8M
- HUYA 827.0M
- IPO Year
- COLL 2015
- HUYA 2018
- Fundamental
- Price
- COLL $36.04
- HUYA $3.49
- Analyst Decision
- COLL Strong Buy
- HUYA Buy
- Analyst Count
- COLL 4
- HUYA 3
- Target Price
- COLL $44.25
- HUYA $4.57
- AVG Volume (30 Days)
- COLL 463.5K
- HUYA 1.6M
- Earning Date
- COLL 11-06-2025
- HUYA 11-11-2025
- Dividend Yield
- COLL N/A
- HUYA 70.64%
- EPS Growth
- COLL N/A
- HUYA N/A
- EPS
- COLL 1.06
- HUYA N/A
- Revenue
- COLL $707,007,000.00
- HUYA $852,782,043.00
- Revenue This Year
- COLL $22.23
- HUYA $8.09
- Revenue Next Year
- COLL $2.78
- HUYA $4.90
- P/E Ratio
- COLL $34.38
- HUYA N/A
- Revenue Growth
- COLL 22.61
- HUYA N/A
- 52 Week Low
- COLL $23.23
- HUYA $2.21
- 52 Week High
- COLL $42.29
- HUYA $6.43
- Technical
- Relative Strength Index (RSI)
- COLL 45.96
- HUYA 51.65
- Support Level
- COLL $34.71
- HUYA $3.31
- Resistance Level
- COLL $36.57
- HUYA $3.55
- Average True Range (ATR)
- COLL 1.25
- HUYA 0.19
- MACD
- COLL -0.59
- HUYA -0.01
- Stochastic Oscillator
- COLL 25.25
- HUYA 34.91
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About HUYA HUYA Inc. American depositary shares each representing one ordinary share
Established in 2011, Huya is the largest online game livestreaming company in China. Headquartered in Guangzhou, Huya mainly provides livestreamed videos on esports games such as League of Legends and Honor of Kings and collects virtual tips from viewers. Its products include the Huya Live platform in China and Nimo TV in Southeast Asia and South America. As of 2024, Huya was a subsidiary of Tencent, which owned 63% of its equity stake and held 94% of the voting power.